1390 RNA nanoparticle vaccines overcome the immunosuppressive tumor microenvironment of metastatic osteosarcoma

John Ligon; Brian Stover; Hector Mendez-Gomez; Adam Grippin; Frances Weidert; Lana Fagman; Jonathan Chardon-Robles; Paul Castillo; Natalie Silver; Joanne Lagmay; Rowan Milner; Duane Mitchell; Elias Sayour

doi:10.1136/jitc-2022-SITC2022.1390

Article info

PDF

Regular and Young Investigator Award Abstracts

Novel Single-Agent Immunotherapies

1390 RNA nanoparticle vaccines overcome the immunosuppressive tumor microenvironment of metastatic osteosarcoma

Free

Authors

John Ligon University of Florida, Gainesville, FL, USA PubMed articles Google scholar articles
Brian Stover University of Florida, Gainesville, FL, USA PubMed articles Google scholar articles
Hector Mendez-Gomez University of Florida, Gainesville, FL, USA PubMed articles Google scholar articles
Adam Grippin University of Florida, Gainesville, FL, USA PubMed articles Google scholar articles
Frances Weidert University of Florida, Gainesville, FL, USA PubMed articles Google scholar articles
Lana Fagman University of Florida, Gainesville, FL, USA PubMed articles Google scholar articles
Jonathan Chardon-Robles University of Florida, Gainesville, FL, USA PubMed articles Google scholar articles
Paul Castillo University of Florida, Gainesville, FL, USA PubMed articles Google scholar articles
Natalie Silver Cleveland Clinic, Cleveland, USA PubMed articles Google scholar articles
Joanne Lagmay University of Florida, Gainesville, FL, USA PubMed articles Google scholar articles
Rowan Milner UF College of Veterinary Medicine, Gainesville, FL, USA PubMed articles Google scholar articles
Duane Mitchell University of Florida, Gainesville, FL, USA PubMed articles Google scholar articles
Elias Sayour University of Florida, Gainesville, FL, USA PubMed articles Google scholar articles

Citation

Ligon J, Stover B, Mendez-Gomez H, et al

1390 RNA nanoparticle vaccines overcome the immunosuppressive tumor microenvironment of metastatic osteosarcoma

Journal for ImmunoTherapy of Cancer 2022;10:doi: 10.1136/jitc-2022-SITC2022.1390

Publication history

First published December 8, 2022.

Online issue publication

April 26, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password